Novo Nordisk’s $1 Billion License Agreement with Lexicon

Leila Ahmed North America Legal Chronicle
Tagged:

Ropes & Gray advised Novo Nordisk on the transaction.Novo Nordisk announced it has entered into an exclusive license agreement with Lexicon Pharmaceuticals (Nasdaq: LXRX) for LX9851,…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here